Items where authors include "Spears, M"

Article

Stewart, I orcid.org/0000-0002-1340-2688, Jacob, J orcid.org/0000-0002-8054-2293, George, PM et al. (75 more authors) (2023) Residual lung abnormalities following COVID-19 hospitalization: interim analysis of the UKILD post-COVID study. American Journal of Respiratory and Critical Care Medicine, 207 (6). pp. 693-703. ISSN 1073-449X

Keir, HR, Long, MB, Abo-Leyah, H et al. (192 more authors) (2022) Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial. The Lancet Respiratory Medicine, 10 (12). pp. 1119-1128. ISSN 2213-2600

Evans, RA, Leavy, OC, Richardson, M et al. (1003 more authors) (2022) Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. The Lancet Respiratory Medicine, 10 (8). pp. 761-775. ISSN 2213-2600

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Wild, JM, Porter, JC, Molyneaux, PL et al. (51 more authors) (2021) Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID). BMJ Open Respiratory Research, 8 (1). e001049. ISSN 2052-4439

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Proceedings Paper

Spears, M, Kalatskaya, I, Trinh, QM et al. (12 more authors) (2018) Targeted sequencing in early breast cancer: Identification of novel candidate mutations predictive of anthracycline benefit. In: Cancer Research. 2017 San Antonio Breast Cancer Symposium, 05-09 Dec 2017, San Antonio, Texas, U.S.A.. American Association for Cancer Research .

Spears, M, Kornaga, E, Lyttle, N et al. (12 more authors) (2018) Validation that a histone gene signature predicts anthracycline response in early breast cancer. In: Cancer Research. 2017 San Antonio Breast Cancer Symposium, 05-09 Dec 2017, San Antonio, Texas, U.S.A.. American Association for Cancer Research. American Association for Cancer Research .